Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For…
Atara Biotherapeutics Inc. (NASDAQ:ATRA) Reports Phase 1a ATA188 Data With Progressive…
MediciNova Inc. (NASDAQ:MNOV) Reports Promising Results Of Its Intranasal BC-PIV SARS-CoV-2…
Oncova Therapeutics Inc. (NASDAQ:ONTX) Commence Phase 1 ON 123300 Study In…
Sorento Therapeutics Inc. (NASDAQ:SRNE) Report Encouraging Phase 1B Resiniferatixin (RTX) Study…
Finance
Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical…
OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply…
TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence…
British Journal of Haematology Publishes Post-Hoc Analysis of Tavalisse for Adults…
Equillium Inc (NASDAQ:EQ) Reports Favorable Results From itolizumab Clinical Trials
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Home
Tags
NASDAQ:NBRV
Tag: NASDAQ:NBRV
CMS Grants NTAP For Nabriva Therapeutics PLC (NASDAQ:NBRV)’s XENLETA For Injection
Gavins Felicity
-
September 23, 2020
0
Nabriva Therapeutics PLC (NASDAQ:NBRV) Inks A Pact With Amplity Health To...
Matt Wade
-
August 21, 2020
0
The European Commission (EC) Issues a Legal Binding Decision for the...
Gavins Felicity
-
July 31, 2020
0
Nabriva Therapeutics (NASDAQ:NBRV) Soars a Deal with Merck & Co., Inc....
Ward Sport
-
July 28, 2020
0
Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Strikes a Marketing and Distribution...
Matt Wade
-
July 21, 2020
0
Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV) Receive The FDA’s Response After...
Matt Wade
-
July 2, 2020
0
EU CHMP Gives Positive Opinion For Nabriva Therapeutics’(NASDAQ:NBRV) XENLETA In Community-Acquired...
Kate Hudson
-
June 10, 2020
0
.td-post-views{ display: none !important; }
